PT-141
Bremelanotide · MC4R-selective analogue
- Brands
- 4
- Best purity
- 99.59%
- From
- £30
- Price spread
- £22
4 brands supply this
Ordered by price · no paid placement
- UPLC-MS · NOR--202608-346Janoshik AnalyticalRetention time (min)λ 214 nm
- Released
- 2026-08-15
- Water (KF)
- 2.81%
- Endotoxin
- 0.142 EU/mg
- UPLC-MS · VER--202608-346Colmaric AnalyticalsRetention time (min)λ 214 nm
- Released
- 2026-08-15
- Water (KF)
- 2.81%
- Endotoxin
- 0.142 EU/mg
- UPLC-MS · HAL--202608-346Janoshik AnalyticalRetention time (min)λ 214 nm
- Released
- 2026-08-15
- Water (KF)
- 2.81%
- Endotoxin
- 0.142 EU/mg
- UPLC-MS · COR--202608-346Peak ChromatographyRetention time (min)λ 214 nm
- Released
- 2026-08-15
- Water (KF)
- 2.81%
- Endotoxin
- 0.142 EU/mg
The compound
The free-acid metabolite of Melanotan II, differing by a single terminal modification that substantially alters receptor selectivity — a textbook SAR pairing.
- CAS number
- 189691-06-3
- Molecular formula
- C50H68N14O10
- Molecular weight
- 1025.16 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- Storage
- −20 °C, desiccated
- Reconstituted
- 2–8 °C, use within 28 days
Primary structure
8 residues
Hover a residue for detail
- Formula
- C50H68N14O10
- Molecular weight
- 1025.16 g/mol
Interactive
Reconstitution calculator
Vial mass
mL
mcg
Syringe
- Draw to
- 5.0 units
- Volume
- 0.050 mL
- Concentration
- 5.00 mg/mL
- Draws per vial
- 40
Arithmetic for PT-141 at the values you entered. Not a protocol and not a dose recommendation. Research use only.